Madrigal Pharma's liver disease drug succeeds in mid-stage trial

(Reuters) - Madrigal Pharmaceuticals Inc said on Thursday a mid-stage trial testing its lead experimental treatment for a liver disease achieved the main goal of reducing liver fat.